Top Markets
#1 B3 (Base) B3 (Base) +15.03%
#2 Siacoin Siacoin +7.20%
#3 OriginTrail OriginTrail +6.85%
#4 Kaia Kaia +5.91%
#5 The Black Bull The Black Bull +5.74%
#6 TROLL TROLL +5.48%
#7 Movement Movement +5.04%
#8 BORA BORA +4.90%
#9 MVL MVL +4.09%
#10 Moo Deng Moo Deng +3.52%
Coin of the day
B3 (Base) B3 (Base)
Settings
Language
ENGLISH
Currency
USD
Theme
BRIM Biotechnology, Inc. BRIM Biotechnology, Inc.

BRIM Biotechnology, Inc.

6885
Rank in Stocks #22414
BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing... BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing innovative regenerative therapies to address both ophthalmic and degenerative joint conditions. Leading its pipeline is BRM 421, a topical ophthalmic solution designed to treat moderate-to-severe dry eye syndrome, which has successfully completed a Phase 2 clinical trial in the United States. The company's development efforts also encompass BRM 423, currently in Phase 1 clinical trials for severe corneal damage; BRM 424, also in Phase 1, targeting neurotrophic keratitis; and BRM 521, which aims to alleviate and repair tissue damage caused by osteoarthritis. Founded in 2013, BRIM Biotechnology is headquartered in Taipei, Taiwan.
Share Price
$0.66936954
Last synced: 2026-07-28
Market Cap
$89.04M
Change (1 day)
0.00%
Change (1 year)
-40.10%
Country
TW
Trade BRIM Biotechnology, Inc. (6885)

Category

Healthcare
Revenue for BRIM Biotechnology, Inc. (6885)
Revenue in Aug 2026 TTM: 0
According to BRIM Biotechnology, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BRIM Biotechnology, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH